Description
This product utilizes γδ T cells that have been engineered with our proprietary GeneCircuit technology to specifically target CD7 (clone T3-3A1G). We employs the pUC (T7-Cy3-IRF-SmaI) vector components and the SynExpress system of the DNA methylation sites Knock-in/Positive feedback for a robust and sustained response against cancers.
Host
Humanized
Target
CD7
Clone
T3-3A1G
Species Reactivity
Human
Cell Source
γδ T cells
Sensor Gene
Cy3
Promoter
T7
Effector Gene
IRF
Insertion Sites
SmaI
Gene Modification
Knock-in
Modification Domain
DNA methylation sites
Carrier Type
pUC
Transformation Accuracy
0.88
Cell Culture
Suspension Culture

For Research Use Only | Not For Clinical Use

Online Inquiry
Related Products
Copyright © 2025 Creative Biolabs. All Rights Reserved.
ISO 9001 Certified - Creative Biolabs Quality Management System.